The global biological control market is anticipated to grow at a significant CAGR of over 12% during the forecast period. The growth of the market is attributed to the factors such as inherently safety, cost-effectiveness, sustainability, and many more. The considerable economic damage caused by insects or pests to the agricultural fields is increasing the […]
Category Archives: Pharmaceuticals
France preventive inhaler market is anticipated to grow at a substantial rate of 3.3% during the forecast period. As per French government agency, Business France, the country ranked as 4th globally and second in Europe for the medical device and technology industry. There are about 1,300 to 1,350 companies in French device manufacturer that generated […]
The global veterinary healthcare market is anticipated to grow at a significant CAGR during the forecast period. In recent decades a lot has changed in terms of availability for veterinary healthcare. The introduction of new treatments and technology in veterinary healthcare such as MRIs, laser surgery, ultrasound, echocardiography, and many more is driving the veterinary […]
The European preventive inhaler market was valued at around $2.8 billion in 2018 and is anticipated to grow at a substantial rate of 1.5% during the forecast period. Major countries that will contribute to the inhaler market within the region includes UK, Germany, France, Italy and Spain. A significant number of companies, research, patient base […]
US preventive inhaler market is anticipated to grow at a substantial rate of 1.2% during the forecast period. The growth of the market of preventive inhalers in the US is mainly driven by factors that include the growing prevalence of chronic diseases such as asthma, diabetes, respiratory lung diseases and so on. Asthma is chronic […]
The US metered dose inhaler market is anticipated to grow at a substantial rate of around 2.0% during the forecast period. The major factors that are contributing significantly to the market growth include rising air pollution, growing geriatric population, and high healthcare expenditure. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological […]
UK metered dose inhaler market is anticipated to grow at a substantial rate of around 2.5% during the forecast period. The metered dose inhalers find a significant role to treat respiratory diseases including asthma, bronchitis, emphysema, and COPD. As the prevalence of asthma and other respiratory diseases increases across UK, the demand for metered dose […]
North American metered dose inhaler market was $2.9 billion in 2018 and is anticipated to grow at a substantial rate of 2.2% during the forecast period. The major factors that are contributing significantly in the market growth include rising air pollution, growing geriatric population, and high healthcare expenditure. The US and Canada are the major […]
The global lysosomal storage disease market is anticipated to grow at a significant rate during the forecast period. Lysosomal storage disease comes under rare diseases. The number of incidences for the disease is around 1 in 7,700 according to the Gaucher’s Disease Foundation. The disease has several symptoms thus it is difficult to identify and […]
Indian preventive inhaler market is anticipated to grow at a substantial rate of 7.0% during the forecast period. Major factors that augments the growth of the market include large population base susceptible to asthma and COPD, rising awareness about treatment for asthma and COPD, and significant presence of market players in the country. The Indian […]